SCHEMBL4565112

SCHEMBL4565112

CCOC(=O)c1sc(N2CCN(CCOc3ccc(C)cc3)C2=O)cc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
KDM4E B2RXH2 3/20 0.40
LMNA P02545 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GRIN1 Q05586 1/20 0.38
GRIN2B Q13224 1/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
POLB P06746 2/20 0.37
RAB9A P51151 1/20 0.37
KCNH2 Q12809 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
ALDH1A1 P00352 2/20 0.37
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KCNA5 P22460 2/20 0.36
CASP7 P55210 1/20 0.36
CASP6 P55212 1/20 0.36
DHODH Q02127 2/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL243891 0.92 NPC1 (0.42) MAPTKDM4ELMNANPSR1MEN1
SCHEMBL243826 0.86 ALDH1A1 (0.42) MAPTKDM4ELMNANPSR1MEN1
SCHEMBL4565114 0.85 TDP1 (0.40) MAPTKDM4ELMNANPSR1MEN1
SCHEMBL244462 0.83 ALOX15 (0.41) MAPTKDM4ELMNANPSR1MEN1
SCHEMBL243640 0.82 LMNA (0.47) MAPTLMNAGRIN1GRIN2BMEN1
SCHEMBL245294 0.80 GAA (0.46) MAPTKDM4ELMNANPSR1MEN1
SCHEMBL243799 0.80 NPC1 (0.38) MAPTKDM4ELMNANPSR1MEN1
SCHEMBL244537 0.78 SCD (0.51) MAPTKDM4ELMNANPSR1MEN1
SCHEMBL241792 0.77 ALOX15 (0.44) MAPTKDM4ELMNANPSR1MEN1
SCHEMBL14047636 0.77 SCD (0.47) MAPTKDM4ELMNANPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054408-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL Novartis Ag (CH) 2009-05-06 EP disclosed
WO-2008127349-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL NOVARTIS AG (CH) 2008-10-23 WO disclosed